THG posts FY25 results ahead of forecasts, sees strong start to 2026

THG reported FY25 adjusted EBITDA of £76.6m, slightly above the £74.9m consensus, with H2 revenue up 6.8% cc (H1 -2.5%) and H2 EBITDA +14% (H1 -35%). The company reiterated FY26 EBITDA guidance of £101m (consensus), expects ~30% EBITDA growth with Nutrition margins improving to 7.4% from 4.2%, and guided FY26 free cash flow of £25-50m; a successful 0% VAT ruling on protein powders could deliver ~£78m cash. Net debt is targeted to fall to £105-130m from £233m in FY25; management booked a ~£7m cash exceptional for Asia Nutrition and flagged guidance assumes no material Middle East escalation impacting supply chains or demand.

Analysis

THG’s narrative shift toward a broader channel mix and licensing-led Nutrition expansion materially changes where operational risk lives. Offline and licensing growth substitutes predictable DTC margins for inventory, receivables and partner-credit risk: a few weeks of elevated inventory days or a larger-than-expected retail return rate would wipe out much of the margin uplift the market is pricing in. Expect headline margin recovery to be lumpy quarter-to-quarter rather than a smooth trajectory, with working capital swings being the dominant short-term sensitivity.

The balance-sheet trajectory is binary around one-time liquidity events and the pace of working-capital normalization. A large cash inflow would rapidly de-lever and increase optionality for M&A or buybacks, but it is a legal/timing event with execution risk; absent that, leverage falls more slowly and refinancing/credit-market sentiment matters. Geopolitical risk is low on direct revenue exposure but non-linear on logistics costs and ingredient sourcing: a supply-shock scenario would transmit quickly through margin-sensitive Nutrition SKUs because of thin retail buffers.

Competitively, incumbents with scale in CPG marketing and retail distribution (large household names) are more vulnerable than traditional pure-play retailers — THG’s channel mix shift enables faster category capture in premium protein and beauty niches if execution holds. Second-order winners include regional contract manufacturers and cold-chain logistics providers where longer-term licensing and offline rollout accelerate demand; losers would be third-party DTC aggregators and wholesale distributors that depend on the old high-volume, low-margin model.

The market’s consensus appears to underweight two asymmetries: (1) the magnitude and timing risk of working-capital tail events that can invert FCF in <6 months, and (2) the optionality embedded in a successful legal cash recovery which the market underprices for equity upside. Positioning should therefore be calibrated to a binary outcome set over the next 3–12 months rather than a smooth multi-year margin story.

Key Decisions for Investors

• Long THG.L via a 9–12 month call spread sized 3–5% of portfolio risk — enter on a pullback of ~8–12% or on visible confirmation of a material cash recovery. Rationale: asymmetric upside if deleveraging proves real; keep downside capped with the spread. Target 40–60% upside vs max premium at risk; trim at 50% of target.
• Pair trade: long THG.L / short RKT.L or ULVR.L (equal notional) for a 6–12 month horizon to isolate digital & nutrition execution vs broad CPG exposure. Rationale: isolates company-specific execution on channel shift; risk if macro consumer spending re-accelerates, in which case the pair may underperform—use a 20% stop on the short leg.
• Event-driven micro-bet: buy small notional 3–6 month OTM calls on THG.L sized <1% portfolio as a binary play on any material legal cash receipt. Rationale: low-cost way to capture outsized upside; risk is total premium loss if outcome fails. Take profits quickly post-announcement and cap notional to avoid skew blowout.
• Tail protection: purchase 6-month puts on THG.L equal to 50–100bps of portfolio value or overlay a put spread to hedge working-capital reversal risk across the next two reporting cycles. Rationale: protects against rapid margin erosion from inventory/returns or geopolitical shipping disruption; accept the insurance premium as cost of asymmetric downside protection.